T21510 |
PSI
|
158442-41-2
|
98%
|
|
PSI is a proteasome inhibitor.
|
TP1961L |
PR 39 (porcine) acetate
|
|
98%
|
|
PR 39 (porcine) acetate is a noncompetitive, reversible and allosteric proteasome inhibitor. PR 39 (porcine) acetate reversibly binds to the α7 subunit of the pr...
|
T16684 |
Puromycin aminonucleoside
|
58-60-6
|
99.97%
|
|
Puromycin aminonucleoside (NSC-3056) increases podocyte permeability by modulating ZO-1 in an oxidative stress-dependent manner.
|
T6203 |
Saxagliptin
|
361442-04-8
|
99.95%
|
|
Saxagliptin (BMS-477118) is a selective and reversible DPP4 inhibitor with IC50 of 26 nM.
|
T4042 |
Talabostat mesylate
|
150080-09-4
|
99.91%
|
|
Talabostat mesylate (PT100) is an orally active, selective inhibitor of dipeptidyl peptidases IV (DPP4, IC50: 0.18 nM), including tumor-associated fibroblast act...
|
T6830 |
Epoxomicin
|
134381-21-8
|
99.91%
|
|
Epoxomicin (BU-4061T,Aids010837) is a selective proteasome inhibitor with anti-inflammatory activity, inhibits primarily the CH-L activity of the 20S proteasome,...
|
T12579 |
RAMB4
|
145888-79-5
|
99.88%
|
|
RAMB4 (PTP1B-IN-9) is a ubiquitin-proteasome system (UPS)-stressor,with anticancer activity.
|
T7917 |
4'-Hydroxychalcone
|
2657-25-2
|
99.86%
|
|
4'-Hydroxychalcone (2-Benzal-4-Hydroxyacetophenone) is a chalcone metabolite with hepatoprotective activity
|
T2745 |
18α-Glycyrrhetinic acid
|
1449-05-4
|
99.83%
|
|
18α-Glycyrrhetinic acid (Enoxolone) is an inhibitor of NF-kB and an activator of the proteasome, and functions as a longevity-promoting and anti-aggregation fact...
|
T0178 |
Saxagliptin hydrate
|
945667-22-1
|
99.8%
|
|
Saxagliptin hydrate (Onglyza hydrate) is a selective and reversible DPP4 inhibitor (IC50: 26 nM; Ki: 1.3 nM).
|
T1674 |
Nateglinide
|
105816-04-4
|
99.78%
|
|
Nateglinide (Senaglinide) is an oral hypoglycemic agent and amino acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy ...
|
T6192 |
Alogliptin
|
850649-61-5
|
99.77%
|
|
Alogliptin (SYR-322)(SYR-322) is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10, 000-fold selectivity over DPP-8 and DPP-9....
|
T2316 |
Omarigliptin
|
1226781-44-7
|
99.70%
|
|
Omarigliptin (MK-3102) has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Chronic Renal Insufficiency.
|
T63321 |
20S Proteasome activator 1
|
2761578-18-9
|
99.68%
|
|
20S Proteasome activator 1 is a 20S proteasome activator with IC50 of 0.3 μM for trypsin-like sites, 0.7 μM for chymotrypsin-like sites and 1.8 μM for caspase si...
|
T0242L |
Sitagliptin phosphate monohydrate
|
654671-77-9
|
99.65%
|
|
Sitagliptin phosphate monohydrate (MK-0431 phosphate monohydrate) is a potent inhibitor of DPP-IV with IC50 of 19 nM in Caco-2 cell extracts.
|
T15079 |
DBPR108
|
1186426-66-3
|
99.65%
|
|
DBPR108 is an orally bioavailable dipeptide-derived DPP4 inhibitor (IC50: 15 nM) and it has no inhibition on DDP8 and DPP9.
|
T0372 |
Gabexate mesylate
|
56974-61-9
|
99.64%
|
|
Gabexate mesylate (FOY) is a serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and...
|
T7016 |
VR23
|
1624602-30-7
|
99.62%
|
|
VR23 is a potent proteasome inhibitor. Data shows IC50 =1 nM for trypsin-like proteasomes, IC50=50-100 nM for chymotrypsin-like proteasomes, and IC50=3 μM for ca...
|
T1795 |
Carfilzomib
|
868540-17-4
|
99.6%
|
|
Carfilzomib (PR-171) is a proteasome inhibitor that irreversibly binds to the chymotrypsin of the 20S proteasome. Carfilzomib has antitumor activity and may be u...
|
T8550 |
NDMC101
|
1308631-40-4
|
99.59%
|
|
NDMC101 is an inhibitor of dipeptidyl peptidase-IV activity in human T cells and exhibits immunomodulatory effects. It also acts as a novel inhibitor of NFATc1 a...
|